For both DNAJA2 and citrate synthase, an immunohistochemical evaluation showed differential protein expression, with both being significantly increased in the MPN-AITL compared with the R-AITL tumors (p = 0.015 and p = 0.007, respectively) (Figure 2E,H). This evidence concerns the gene DNAJA2 and myeloproliferative disorder.